Concerned

ABOUT pH SHIFT?

To know more...

pharmapackaging@nipro-group.com
www.nipro-group.com

To know more...

pharmapackaging@nipro-group.com
www.nipro-group.com

02/24/2024 12:07:12
  • Home | What Rishi Sunak can do for the UK pharma industry
  • In this issue
  • Contents
  • CSafe
  • Tripletree
  • Briefing
  • Industry news
  • The pharma industry briefing
  • BEA Technologies
  • Mimotopes Company Insight
  • Mimotopes
  • Comment
  • GSK speeds up the race to market first RSV vaccine for older adults
  • Biden’s directive on foreign biotech investments impacts manufacturers
  • Novo Nordisk targets FDA approval for once-weekly insulin after Phase III data
  • ‘Twindemic’ risks warrant immediate steps in Europe and the US
  • A game of two halves for Roche’s recently approved wet AMD assets
  • Dr. Paul Lohmann
  • Nipro
  • In Depth
  • What Rishi Sunak can do for the UK pharma industry
  • Inside the European mass shift to data-driven health solutions
  • Chronic drug shortages signal difficult outlook for cardiovascular care
  • Can gene therapies for haemophilia defend their high price tags?
  • Trial termination analysis unveils a silver lining for patient recruitment
  • New dawn for the EU's joint procurement crisis response
  • Skyepharma
  • Bio Image Systems Inc.
  • In Data
  • The pharma industry found it easier to fill AI vacancies in Q3 2022
  • Internet of things hiring levels in the pharma dropped in October 2022
  • Artificial intelligence hiring levels in the pharma dropped in October 2022
  • Baxter
  • Events
  • Next issue
11/21/2022 00:00:00